{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:23:42Z","timestamp":1773685422972,"version":"3.50.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30 NR016587"],"award-info":[{"award-number":["P30 NR016587"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001873"],"award-info":[{"award-number":["UL1 TR001873"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["R01 NR017206"],"award-info":[{"award-number":["R01 NR017206"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["R01 NR017206"],"award-info":[{"award-number":["R01 NR017206"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hydroxyurea (HU) is recommended as standard practice for youth with sickle cell disease (SCD). Yet, despite its efficacy, HU adherence in adolescents and young adults is often poor. Poor medication adherence increases disease burden, healthcare cost and widens health disparities. Adolescence is a critical time to improve adherence through improved chronic disease self-management. This study aims to test the efficacy of an intervention delivered to youth\/parent dyads by community health workers (CHWs), augmented by tailored text messages on HU adherence (primary outcome). Secondary outcomes are intervention sustainability, youth health-related quality of life, self-management responsibility concordance, acute hospital use and self-reported disease symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Hydroxyurea Adherence for Personal Best in Sickle Cell Disease, \u201cHABIT,\u201d is a 12\u2009month multi-center randomized controlled trial. One hundred four youth, 10 to 18\u2009years of age prescribed HU who meet eligibility criteria, enrolled with their parent as dyads, will be randomized 1:1 to either the HABIT intervention or to usual clinical care plus education handouts. All subjects will complete clinic visits at months 0, 2, 4, 6 (efficacy component), 9 and 12 (sustainability component) for assessment of HbF biomarker, other hematologic parameters, and to complete questionnaires. In addition, dyads assigned to the HABIT intervention will work with CHWs to identify a daily habit (e.g., brushing teeth) on which to build a HU adherence habit. Tailored daily text message reminders to support the habit will be developed by the dyad in collaboration with the CHWs and sent to parent and youth. At the 6\u2009month visit, the intervention will end and the sustainability portion of the trial will begin. All data analyses will be based on intention to treat with all randomized subjects included in the analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Prior retrospective studies demonstrate that a majority of adolescents are poorly adherent to HU. If efficacious, the HABIT intervention has the potential to improve the lives of youth with SCD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>Clinicaltrials.gov<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03462511\">NCT03462511<\/jats:ext-link>. Registered March 6, 2018, last updated July 26, 2019.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12887-019-1746-6","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T11:22:10Z","timestamp":1571138530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-5036","authenticated-orcid":false,"given":"Arlene","family":"Smaldone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Manwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Aygun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Smith-Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haomiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Findley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Massei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy S.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"issue":"4 Suppl","key":"1746_CR1","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","volume":"38","author":"KL Hassell","year":"2010","unstructured":"Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512\u201321.","journal-title":"Am J Prev Med"},{"issue":"1","key":"1746_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","volume":"85","author":"DC Brousseau","year":"2010","unstructured":"Brousseau DC, et al. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol. 2010;85(1):77\u20138.","journal-title":"Am J Hematol"},{"issue":"13","key":"1746_CR3","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.2010.378","volume":"303","author":"DC Brousseau","year":"2010","unstructured":"Brousseau DC, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010;303(13):1288\u201394.","journal-title":"JAMA"},{"issue":"4","key":"1746_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/pbc.24065","volume":"59","author":"JL Raphael","year":"2012","unstructured":"Raphael JL, et al. Shorter hospitalization trends among children with sickle cell disease. Pediatr Blood Cancer. 2012;59(4):679\u201384.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1746_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/003335491312800206","volume":"128","author":"S Lanzkron","year":"2013","unstructured":"Lanzkron S, Carroll CP, Haywood C Jr. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. Public Health Rep. 2013;128(2):110\u20136.","journal-title":"Public Health Rep"},{"issue":"9","key":"1746_CR6","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/pbc.24557","volume":"60","author":"D Hamideh","year":"2013","unstructured":"Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer. 2013;60(9):1482\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"1746_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033\u201348.","journal-title":"JAMA"},{"issue":"4","key":"1746_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/MPH.0b013e3182114c54","volume":"33","author":"CD Thornburg","year":"2011","unstructured":"Thornburg CD, Calatroni A, Panepinto JA. Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. J Pediatr Hematol Oncol. 2011;33(4):251\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"1746_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/MOH.0b013e32834521dd","volume":"18","author":"PT McGann","year":"2011","unstructured":"McGann PT, Ware RE. Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? Curr Opin Hematol. 2011;18(3):158\u201365.","journal-title":"Curr Opin Hematol"},{"issue":"26","key":"1746_CR10","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","volume":"115","author":"RE Ware","year":"2010","unstructured":"Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood. 2010;115(26):5300\u201311.","journal-title":"Blood"},{"issue":"3","key":"1746_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ajh.21968","volume":"86","author":"SD Candrilli","year":"2011","unstructured":"Candrilli SD, et al. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol. 2011;86(3):273\u20137.","journal-title":"Am J Hematol"},{"issue":"9","key":"1746_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ajh.22101","volume":"86","author":"AM Brandow","year":"2011","unstructured":"Brandow AM, Panepinto JA. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. Am J Hematol. 2011;86(9):804\u20136.","journal-title":"Am J Hematol"},{"issue":"10","key":"1746_CR13","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/ajh.22134","volume":"86","author":"J Ritho","year":"2011","unstructured":"Ritho J, et al. Hydroxyurea use in patients with sickle cell disease in a Medicaid population. Am J Hematol. 2011;86(10):888\u201390.","journal-title":"Am J Hematol"},{"issue":"3","key":"1746_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jpeds.2009.09.044","volume":"156","author":"CD Thornburg","year":"2010","unstructured":"Thornburg CD, et al. Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr. 2010;156(3):415\u20139.","journal-title":"J Pediatr"},{"issue":"6","key":"1746_CR15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1542\/peds.2014-0177","volume":"134","author":"KE Walsh","year":"2014","unstructured":"Walsh KE, et al. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics. 2014;134(6):1175\u201383.","journal-title":"Pediatrics"},{"issue":"12","key":"1746_CR16","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/pbc.26161","volume":"63","author":"NS Green","year":"2016","unstructured":"Green NS, et al. Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use. Pediatr Blood Cancer. 2016;63(12):2146\u201353.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1746_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/QAI.0b013e3181c57dbc","volume":"53","author":"LM Bogart","year":"2010","unstructured":"Bogart LM, et al. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV. J Acquir Immune Defic Syndr. 2010;53(5):648\u201355.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"1746_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/jpepsy\/jsm030","volume":"32","author":"LE Simons","year":"2007","unstructured":"Simons LE, Blount RL. Identifying barriers to medication adherence in adolescent transplant recipients. J Pediatr Psychol. 2007;32(7):831\u201344.","journal-title":"J Pediatr Psychol"},{"issue":"4","key":"1746_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/pbc.24381","volume":"60","author":"SO Oyeku","year":"2013","unstructured":"Oyeku SO, et al. Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease. Pediatr Blood Cancer. 2013;60(4):653\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1746_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jpepsy\/jsg022","volume":"28","author":"EL McQuaid","year":"2003","unstructured":"McQuaid EL, et al. Medication adherence in pediatric asthma: reasoning, responsibility, and behavior. J Pediatr Psychol. 2003;28(5):323\u201333.","journal-title":"J Pediatr Psychol"},{"issue":"11","key":"1746_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/PEC.0000000000000259","volume":"30","author":"EM Delgado","year":"2014","unstructured":"Delgado EM, et al. Parental asthma education and risks for nonadherence to pediatric asthma treatments. Pediatr Emerg Care. 2014;30(11):782\u20137.","journal-title":"Pediatr Emerg Care"},{"issue":"6","key":"1746_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1542\/peds.2012-0668","volume":"130","author":"LE Wisk","year":"2012","unstructured":"Wisk LE, Witt WP. Predictors of delayed or forgone needed health care for families with children. Pediatrics. 2012;130(6):1027\u201337.","journal-title":"Pediatrics"},{"issue":"4","key":"1746_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1464-5491.2004.01449.x","volume":"22","author":"G Reach","year":"2005","unstructured":"Reach G. Role of habit in adherence to medical treatment. Diabet Med. 2005;22(4):415\u201320.","journal-title":"Diabet Med"},{"issue":"4","key":"1746_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1542\/peds.2013-1451","volume":"132","author":"ME McGrady","year":"2013","unstructured":"McGrady ME, Hommel KA. Medication adherence and health care utilization in pediatric chronic illness: a systematic review. Pediatrics. 2013;132(4):730\u201340.","journal-title":"Pediatrics"},{"issue":"6","key":"1746_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11882-011-0227-2","volume":"11","author":"M Desai","year":"2011","unstructured":"Desai M, Oppenheimer JJ. Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep. 2011;11(6):454\u201364.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"1746_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/pch\/13.1.19","volume":"13","author":"D Taddeo","year":"2008","unstructured":"Taddeo D, Egedy M, Frappier JY. Adherence to treatment in adolescents. Paediatr Child Health. 2008;13(1):19\u201324.","journal-title":"Paediatr Child Health"},{"issue":"1","key":"1746_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1378\/chest.13-1926","volume":"146","author":"AL Quittner","year":"2014","unstructured":"Quittner AL, et al. Pulmonary medication adherence and health-care use in cystic fibrosis. Chest. 2014;146(1):142\u201351.","journal-title":"Chest"},{"issue":"7","key":"1746_CR28","doi-asserted-by":"publisher","first-page":"e27740","DOI":"10.1002\/pbc.27740","volume":"66","author":"A Smaldone","year":"2019","unstructured":"Smaldone A, Manwani D, Green NS. Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease. Pediatr Blood Cancer. 2019;66(7):e27740.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1746_CR29","doi-asserted-by":"publisher","first-page":"e912","DOI":"10.1542\/peds.2007-1484","volume":"121","author":"RL Rothman","year":"2008","unstructured":"Rothman RL, et al. Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes. Pediatrics. 2008;121(4):e912\u20139.","journal-title":"Pediatrics"},{"issue":"2","key":"1746_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11606-017-4199-3","volume":"33","author":"EL McQuaid","year":"2018","unstructured":"McQuaid EL, Landier W. Cultural issues in medication adherence: disparities and directions. J Gen Intern Med. 2018;33(2):200\u20136.","journal-title":"J Gen Intern Med"},{"key":"1746_CR31","first-page":"35","volume":"7","author":"AO Iuga","year":"2014","unstructured":"Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35\u201344.","journal-title":"Risk Manag Healthc Policy"},{"issue":"4","key":"1746_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jpepsy\/jsp073","volume":"35","author":"AL Pai","year":"2010","unstructured":"Pai AL, Drotar D. Treatment adherence impact: the systematic assessment and quantification of the impact of treatment adherence on pediatric medical and psychological outcomes. J Pediatr Psychol. 2010;35(4):383\u201393.","journal-title":"J Pediatr Psychol"},{"issue":"1 Suppl 1","key":"1746_CR33","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.amepre.2016.01.001","volume":"51","author":"DG Anders","year":"2016","unstructured":"Anders DG, et al. Hydroxyurea use in young children with sickle cell anemia in New York state. Am J Prev Med. 2016;51(1 Suppl 1):S31\u20138.","journal-title":"Am J Prev Med"},{"key":"1746_CR34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/ajh.24906","volume":"92","author":"JH Estepp","year":"2017","unstructured":"Estepp JH, et al. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy. Am J Hematol. 2017;92:1333\u20139.","journal-title":"Am J Hematol"},{"issue":"11","key":"1746_CR35","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/pbc.25177","volume":"61","author":"JH Estepp","year":"2014","unstructured":"Estepp JH, et al. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia. Pediatr Blood Cancer. 2014;61(11):2031\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1746_CR36","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/pbc.24931","volume":"61","author":"SE Creary","year":"2014","unstructured":"Creary SE, et al. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease. Pediatr Blood Cancer. 2014;61(6):1068\u201373.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1746_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12185-016-2027-x","volume":"104","author":"S Inoue","year":"2016","unstructured":"Inoue S, et al. Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study. Int J Hematol. 2016;104(2):200\u20137.","journal-title":"Int J Hematol"},{"issue":"2","key":"1746_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4338\/ACI-2016-12-RA-0203","volume":"8","author":"BM Pernell","year":"2017","unstructured":"Pernell BM, et al. Improving medication adherence with two-way short message service reminders in sickle cell disease and asthma. A feasibility randomized controlled trial. Appl Clin Inform. 2017;8(2):541\u201359.","journal-title":"Appl Clin Inform"},{"issue":"Suppl 3","key":"1746_CR39","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1542\/peds.2017-1284H","volume":"141","author":"P Lozano","year":"2018","unstructured":"Lozano P, Houtrow A. Supporting self-management in children and adolescents with complex chronic conditions. Pediatrics. 2018;141(Suppl 3):S233\u201341.","journal-title":"Pediatrics"},{"issue":"2","key":"1746_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/jpepsy\/jsn065","volume":"34","author":"S Naar-King","year":"2009","unstructured":"Naar-King S, et al. Allocation of family responsibility for illness management in pediatric HIV. J Pediatr Psychol. 2009;34(2):187\u201394.","journal-title":"J Pediatr Psychol"},{"issue":"2","key":"1746_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0022-3476(97)70352-4","volume":"130","author":"B Anderson","year":"1997","unstructured":"Anderson B, et al. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1997;130(2):257\u201365.","journal-title":"J Pediatr"},{"issue":"6","key":"1746_CR42","doi-asserted-by":"publisher","first-page":"e1186","DOI":"10.1542\/peds.2008-0292","volume":"122","author":"JK Orrell-Valente","year":"2008","unstructured":"Orrell-Valente JK, et al. At what age do children start taking daily asthma medicines on their own? Pediatrics. 2008;122(6):e1186\u201392.","journal-title":"Pediatrics"},{"issue":"1","key":"1746_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/02770900009055432","volume":"37","author":"N Walders","year":"2000","unstructured":"Walders N, Drotar D, Kercsmar C. The allocation of family responsibility for asthma management tasks in African-American adolescents. J Asthma. 2000;37(1):89\u201399.","journal-title":"J Asthma"},{"issue":"4","key":"1746_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/jpepsy\/15.4.477","volume":"15","author":"BJ Anderson","year":"1990","unstructured":"Anderson BJ, et al. Assessing family sharing of diabetes responsibilities. J Pediatr Psychol. 1990;15(4):477\u201392.","journal-title":"J Pediatr Psychol"},{"issue":"5","key":"1746_CR45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2337\/diacare.22.5.713","volume":"22","author":"BJ Anderson","year":"1999","unstructured":"Anderson BJ, et al. An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care. 1999;22(5):713\u201321.","journal-title":"Diabetes Care"},{"issue":"5","key":"1746_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/pbc.20290","volume":"44","author":"MJ Treadwell","year":"2005","unstructured":"Treadwell MJ, et al. Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer. 2005;44(5):500\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1746_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2174\/1573399811666150421114146","volume":"11","author":"JT Markowitz","year":"2015","unstructured":"Markowitz JT, Garvey KC, Laffel LM. Developmental changes in the roles of patients and families in type 1 diabetes management. Curr Diabetes Rev. 2015;11(4):231\u20138.","journal-title":"Curr Diabetes Rev"},{"issue":"2","key":"1746_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jadohealth.2013.08.009","volume":"54","author":"S Hanghoj","year":"2014","unstructured":"Hanghoj S, Boisen KA. Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review. J Adolesc Health. 2014;54(2):121\u201338.","journal-title":"J Adolesc Health"},{"issue":"6","key":"1746_CR49","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1182\/blood-2003-07-2475","volume":"103","author":"SA Zimmerman","year":"2004","unstructured":"Zimmerman SA, et al. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood. 2004;103(6):2039\u201345.","journal-title":"Blood"},{"issue":"28","key":"1746_CR50","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1097\/MD.0000000000000215","volume":"93","author":"JS Hankins","year":"2014","unstructured":"Hankins JS, et al. From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia. Medicine (Baltimore). 2014;93(28):e215.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1746_CR51","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1182\/blood.V97.11.3628","volume":"97","author":"A Ferster","year":"2001","unstructured":"Ferster A, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood. 2001;97(11):3628\u201332.","journal-title":"Blood"},{"issue":"13","key":"1746_CR52","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMct0708272","volume":"358","author":"OS Platt","year":"2008","unstructured":"Platt OS. Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med. 2008;358(13):1362\u20139.","journal-title":"N Engl J Med"},{"key":"1746_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jpeds.2018.01.054","volume":"197","author":"A Smaldone","year":"2018","unstructured":"Smaldone A, et al. HABIT, a randomized feasibility trial to increase hydroxyurea adherence, suggests improved health-related quality of life in youths with sickle cell disease. J Pediatr. 2018;197:177\u2013185.e2.","journal-title":"J Pediatr"},{"issue":"12","key":"1746_CR54","doi-asserted-by":"publisher","first-page":"e26689","DOI":"10.1002\/pbc.26689","volume":"64","author":"Nancy S. Green","year":"2017","unstructured":"Green NS, et al. Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: the HABIT study. Pediatr Blood Cancer. 2017;64(12). https:\/\/doi.org\/10.1002\/pbc.26689 .","journal-title":"Pediatric Blood & Cancer"},{"issue":"1","key":"1746_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1182\/blood.V99.1.10","volume":"99","author":"RE Ware","year":"2002","unstructured":"Ware RE, et al. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood. 2002;99(1):10\u20134.","journal-title":"Blood"},{"issue":"8","key":"1746_CR56","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.2105\/AJPH.2011.300585","volume":"102","author":"PJ Peretz","year":"2012","unstructured":"Peretz PJ, et al. Community health workers as drivers of a successful community-based disease management initiative. Am J Public Health. 2012;102(8):1443\u20136.","journal-title":"Am J Public Health"},{"issue":"10","key":"1746_CR57","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2105\/AJPH.2011.300566","volume":"102","author":"SE Findley","year":"2012","unstructured":"Findley SE, et al. Building a consensus on community health workers\u2019 scope of practice: lessons from New York. Am J Public Health. 2012;102(10):1981\u20137.","journal-title":"Am J Public Health"},{"issue":"7","key":"1746_CR58","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s11606-015-3247-0","volume":"30","author":"W Palmas","year":"2015","unstructured":"Palmas W, et al. Community health worker interventions to improve glycemic control in people with diabetes: a systematic review and meta-analysis. J Gen Intern Med. 2015;30(7):1004\u201312.","journal-title":"J Gen Intern Med"},{"key":"1746_CR59","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12913-014-0497-1","volume":"14","author":"I Verhagen","year":"2014","unstructured":"Verhagen I, et al. Community health worker interventions to improve access to health care services for older adults from ethnic minorities: a systematic review. BMC Health Serv Res. 2014;14:497.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"1746_CR60","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.2105\/AJPH.2015.302987","volume":"106","author":"K Kim","year":"2016","unstructured":"Kim K, et al. Effects of community-based health worker interventions to improve chronic disease management and care among vulnerable populations: a systematic review. Am J Public Health. 2016;106(4):e3\u2013e28.","journal-title":"Am J Public Health"},{"issue":"5","key":"1746_CR61","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.acap.2013.04.015","volume":"13","author":"JL Raphael","year":"2013","unstructured":"Raphael JL, et al. The role of lay health workers in pediatric chronic disease: a systematic review. Acad Pediatr. 2013;13(5):408\u201320.","journal-title":"Acad Pediatr"},{"issue":"1 Suppl 1","key":"1746_CR62","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.amepre.2016.01.016","volume":"51","author":"LL Hsu","year":"2016","unstructured":"Hsu LL, et al. Community health workers as support for sickle cell care. Am J Prev Med. 2016;51(1 Suppl 1):S87\u201398.","journal-title":"Am J Prev Med"},{"issue":"5","key":"1746_CR63","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10995-014-1595-8","volume":"19","author":"E Poorman","year":"2015","unstructured":"Poorman E, et al. Use of text messaging for maternal and infant health: a systematic review of the literature. Matern Child Health J. 2015;19(5):969\u201389.","journal-title":"Matern Child Health J"},{"issue":"5","key":"1746_CR64","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.2196\/mhealth.7798","volume":"5","author":"SM Badawy","year":"2017","unstructured":"Badawy SM, et al. Text messaging and mobile phone apps as interventions to improve adherence in adolescents with chronic health conditions: a systematic review. JMIR Mhealth Uhealth. 2017;5(5):e66.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"4","key":"1746_CR65","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.2196\/mhealth.6837","volume":"5","author":"SM Badawy","year":"2017","unstructured":"Badawy SM, Kuhns LM. Texting and mobile phone app interventions for improving adherence to preventive behavior in adolescents: a systematic review. JMIR Mhealth Uhealth. 2017;5(4):e50.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"1746_CR66","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4081\/jphr.2015.376","volume":"4","author":"A Smaldone","year":"2015","unstructured":"Smaldone A, et al. Adolescent and parent use of new technologies for health communication: a study in an urban latino community. J Public Health Res. 2015;4(1):376.","journal-title":"J Public Health Res"},{"issue":"7","key":"1746_CR67","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.2337\/dc09-2268","volume":"33","author":"KK Hood","year":"2010","unstructured":"Hood KK, et al. Interventions with adherence-promoting components in pediatric type 1 diabetes: meta-analysis of their impact on glycemic control. Diabetes Care. 2010;33(7):1658\u201364.","journal-title":"Diabetes Care"},{"issue":"6","key":"1746_CR68","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/jpepsy\/jsm128","volume":"33","author":"S Kahana","year":"2008","unstructured":"Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol. 2008;33(6):590\u2013611.","journal-title":"J Pediatr Psychol"},{"key":"1746_CR69","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cct.2016.06.004","volume":"49","author":"A Smaldone","year":"2016","unstructured":"Smaldone A, et al. Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease. Contemp Clin Trials. 2016;49:134\u201342.","journal-title":"Contemp Clin Trials"},{"issue":"5","key":"1746_CR70","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.outlook.2006.06.004","volume":"54","author":"M Grey","year":"2006","unstructured":"Grey M, Knafl K, McCorkle R. A framework for the study of self- and family management of chronic conditions. Nurs Outlook. 2006;54(5):278\u201386.","journal-title":"Nurs Outlook"},{"issue":"2","key":"1746_CR71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.outlook.2014.10.003","volume":"63","author":"M Grey","year":"2015","unstructured":"Grey M, et al. A revised self- and family management framework. Nurs Outlook. 2015;63(2):162\u201370.","journal-title":"Nurs Outlook"},{"issue":"605","key":"1746_CR72","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3399\/bjgp12X659466","volume":"62","author":"B Gardner","year":"2012","unstructured":"Gardner B, Lally P, Wardle J. Making health habitual: the psychology of \u2018habit-formation\u2019 and general practice. Br J Gen Pract. 2012;62(605):664\u20136.","journal-title":"Br J Gen Pract"},{"key":"1746_CR73","first-page":"407","volume-title":"Health behavior and health education: theory, research and practice","author":"AC Gielen","year":"2008","unstructured":"Gielen AC, et al. Using the PRECEDE\/PROCEED model to apply health behavior theories. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health education: theory, research and practice. San Francisco: Jossey-Bass; 2008. p. 407\u201333."},{"issue":"4","key":"1746_CR74","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/1524839908328992","volume":"11","author":"JN Slawta","year":"2010","unstructured":"Slawta JN, DeNeui D. Be a fit kid: nutrition and physical activity for the fourth grade. Health Promot Pract. 2010;11(4):522\u20139.","journal-title":"Health Promot Pract"},{"issue":"2","key":"1746_CR75","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jneb.2008.03.006","volume":"41","author":"RE Cole","year":"2009","unstructured":"Cole RE, Horacek T. Applying precede-proceed to develop an intuitive eating nondieting approach to weight management pilot program. J Nutr Educ Behav. 2009;41(2):120\u20136.","journal-title":"J Nutr Educ Behav"},{"issue":"Suppl 1","key":"1746_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1467-789X.2011.00974.x","volume":"13","author":"Y Manios","year":"2012","unstructured":"Manios Y, et al. A systematic approach for the development of a kindergarten-based intervention for the prevention of obesity in preschool age children: the ToyBox-study. Obes Rev. 2012;13(Suppl 1):3\u201312.","journal-title":"Obes Rev"},{"issue":"21","key":"1746_CR77","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1001\/jama.2018.6360","volume":"319","author":"K Broglio","year":"2018","unstructured":"Broglio K. Randomization in clinical trials: permuted blocks and stratification. JAMA. 2018;319(21):2223\u20134.","journal-title":"JAMA"},{"issue":"11","key":"1746_CR78","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jpain.2010.02.005","volume":"11","author":"JW Varni","year":"2010","unstructured":"Varni JW, et al. PROMIS pediatric pain interference scale: an item response theory analysis of the pediatric pain item bank. J Pain. 2010;11(11):1109\u201319.","journal-title":"J Pain"},{"issue":"6","key":"1746_CR79","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/pbc.25931","volume":"63","author":"C Dampier","year":"2016","unstructured":"Dampier C, et al. Responsiveness of PROMIS(R) pediatric measures to hospitalizations for sickle pain and subsequent recovery. Pediatr Blood Cancer. 2016;63(6):1038\u201345.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1746_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11136-015-1058-8","volume":"25","author":"D Thissen","year":"2016","unstructured":"Thissen D, et al. Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method. Qual Life Res. 2016;25(1):13\u201323.","journal-title":"Qual Life Res"},{"key":"1746_CR81","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/asheducation-2017.1.542","volume":"1","author":"S Curtis","year":"2017","unstructured":"Curtis S, Brandow AM. Responsiveness of patient-reported outcome measurement information system (PROMIS) pain domains and disease-specific patient-reported outcome measures in children and adulsts with sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017;1:542\u20135.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"1746_CR82","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s11136-013-0357-1","volume":"22","author":"JS Lai","year":"2013","unstructured":"Lai JS, et al. Development and psychometric properties of the PROMIS((R)) pediatric fatigue item banks. Qual Life Res. 2013;22(9):2417\u201327.","journal-title":"Qual Life Res"},{"issue":"8","key":"1746_CR83","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800\u201312.","journal-title":"Med Care"},{"issue":"8","key":"1746_CR84","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/pbc.24491","volume":"60","author":"JA Panepinto","year":"2013","unstructured":"Panepinto JA, et al. PedsQL sickle cell disease module: feasibility, reliability, and validity. Pediatr Blood Cancer. 2013;60(8):1338\u201344.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1746_CR85","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1037\/a0015759","volume":"27","author":"BJ Anderson","year":"2009","unstructured":"Anderson BJ, et al. Dyadic measures of the parent-child relationship during the transition to adolescence and glycemic control in children with type 1 diabetes. Fam Syst Health. 2009;27(2):141\u201352.","journal-title":"Fam Syst Health"},{"key":"1746_CR86","volume-title":"Content analysis: an introduction to its methodology","author":"KH Krippendorff","year":"2012","unstructured":"Krippendorff KH. Content analysis: an introduction to its methodology. 3rd ed. Thousand Oaks: Sage Publications, Inc.; 2012.","edition":"3"},{"key":"1746_CR87","doi-asserted-by":"crossref","DOI":"10.4135\/9781071802878","volume-title":"The content analysis guidebook","author":"KA Neuendorf","year":"2017","unstructured":"Neuendorf KA. The content analysis guidebook. 2nd ed. Thousand Oaks: Sage Publications, Inc.; 2017.","edition":"2"},{"issue":"1","key":"1746_CR88","doi-asserted-by":"publisher","first-page":"e20183285","DOI":"10.1542\/peds.2018-3285","volume":"144","author":"David C. Brousseau","year":"2019","unstructured":"Brousseau DC, et al. Hydroxyurea use for sickle cell disease among medicaid-enrolled children. Pediatrics. 2019;144(1). https:\/\/doi.org\/10.1542\/peds.2018-3285 .","journal-title":"Pediatrics"},{"issue":"6","key":"1746_CR89","doi-asserted-by":"publisher","first-page":"e27721","DOI":"10.1002\/pbc.27721","volume":"66","author":"SL Reeves","year":"2019","unstructured":"Reeves SL, et al. Hydroxyurea use among children with sickle cell anemia. Pediatr Blood Cancer. 2019;66(6):e27721.","journal-title":"Pediatr Blood Cancer"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1746-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T01:10:36Z","timestamp":1721869836000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1746-6","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]},"assertion":[{"value":"15 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prior to recruitment the study was approved by the Institutional Review Board at Columbia University Medical Center (Protocol number AAAR2908) and at each participating clinical site. Prior to study participation, eligible parent youth dyads willing to participate will sign a written consent and\/or assent. The consenting process will be conducted in either Spanish or English depending on dyad preference.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}